Benzoxazines are a type of heterocyclic compounds consisting of benzene and oxazine rings. Benzoxazine research is developing rapidly because of the many potential applications of the materials.
Reviva announced an enrollment update to the ongoing 1-year open-label extension (OLE) study evaluating the long-term safety and tolerability of Brilaroxazine in patients with schizophrenia.
Brilaroxazine is a discovered new chemical entity with potent affinity and selectivity against key serotonin and dopamine receptors implicated in schizophrenia and its comorbid symptoms.
検索 
+86 21 5895 0110 
